Applicant, as named in the Orange Book

Sun Pharm Inds Inc

Part of Sun Pharmaceutical Industries

Company and ticker: cliffwatch mapping, checked against SEC EDGAR

Next listed expiry: Levulan on 12 Jan 2038. 3 products with live protection, 4 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Levulan NDA 020965 aminolevulinic acid hydrochloride	aminolevulinic acid hydrochloride	12 Jan 2038 patent, carve-out possible	patent, carve-out possible
Sezaby NDA 215910 phenobarbital sodium	phenobarbital sodium	7 Apr 2042 patent	patent
Leqselvi NDA 217900 deuruxolitinib phosphate	deuruxolitinib phosphate	10 Oct 2044 patent, carve-out possible	patent, carve-out possible

Lac-Hydrin · Generic approved · ANDA 217758, Zydus LifesciencesApproved 15 May 2026Detected 25 Oct 2026
Lac-Hydrin · Generic approved · ANDA 217815, Zydus LifesciencesApproved 12 Feb 2026Detected 25 Oct 2026
Absorica · Generic approved · ANDA 216097, Amneal Pharms NyApproved 7 Oct 2025Detected 25 Oct 2026
Absorica · Generic approved · ANDA 220336, Aurobindo Pharma LtdApproved 10 Sep 2026Detected 25 Oct 2026

Products without listed protection (4)

Drug	Ingredient	Earliest generic entry	Basis
Absorica NDA 021951 · 6 strengths isotretinoin	isotretinoin	open now no listed protection	no listed protection
An-Sulfur Colloid NDA 017858 technetium tc-99m sulfur colloid kit	technetium tc-99m sulfur colloid kit	open now no listed protection	no listed protection
Halog NDA 017823 halcinonide	halcinonide	open now no listed protection	no listed protection
Halog NDA 017556 halcinonide	halcinonide	open now no listed protection	no listed protection